BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31594070)

  • 1. [Novel DYRK1A mutations in 2 individuals with autosomal dominant mental retardation-7].
    Zou XM; Xiao H; He HL; Guang SQ; Peng J
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):804-806. PubMed ID: 31594070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DYRK1A pathogenic variants in two patients with syndromic intellectual disability and a review of the literature.
    Meissner LE; Macnamara EF; D'Souza P; Yang J; Vezina G; ; Ferreira CR; Zein WM; Tifft CJ; Adams DR
    Mol Genet Genomic Med; 2020 Dec; 8(12):e1544. PubMed ID: 33159716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report of novel DYRK1A mutations in 2 individuals with syndromic intellectual disability and a review of the literature.
    Luco SM; Pohl D; Sell E; Wagner JD; Dyment DA; Daoud H
    BMC Med Genet; 2016 Feb; 17():15. PubMed ID: 26922654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy.
    Courcet JB; Faivre L; Malzac P; Masurel-Paulet A; Lopez E; Callier P; Lambert L; Lemesle M; Thevenon J; Gigot N; Duplomb L; Ragon C; Marle N; Mosca-Boidron AL; Huet F; Philippe C; Moncla A; Thauvin-Robinet C
    J Med Genet; 2012 Dec; 49(12):731-6. PubMed ID: 23099646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A.
    Bronicki LM; Redin C; Drunat S; Piton A; Lyons M; Passemard S; Baumann C; Faivre L; Thevenon J; Rivière JB; Isidor B; Gan G; Francannet C; Willems M; Gunel M; Jones JR; Gleeson JG; Mandel JL; Stevenson RE; Friez MJ; Aylsworth AS
    Eur J Hum Genet; 2015 Nov; 23(11):1482-7. PubMed ID: 25920557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DYRK1A mutations in two unrelated patients.
    Ruaud L; Mignot C; Guët A; Ohl C; Nava C; Héron D; Keren B; Depienne C; Benoit V; Maystadt I; Lederer D; Amsallem D; Piard J
    Eur J Med Genet; 2015 Mar; 58(3):168-74. PubMed ID: 25641759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID.
    van Bon BW; Coe BP; Bernier R; Green C; Gerdts J; Witherspoon K; Kleefstra T; Willemsen MH; Kumar R; Bosco P; Fichera M; Li D; Amaral D; Cristofoli F; Peeters H; Haan E; Romano C; Mefford HC; Scheffer I; Gecz J; de Vries BB; Eichler EE
    Mol Psychiatry; 2016 Jan; 21(1):126-32. PubMed ID: 25707398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular Phenotype Associated with
    Méjécase C; Way CM; Owen N; Moosajee M
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33562844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a human induced pluripotent stem cell line (FDCHi012-A) from a patient with DYRK1A-related intellectual disability syndrome carrying DYRK1A mutation (c.1024G > T).
    Ge Y; Cheng Y; Yin T; Peng X; Xiong Z; Wu B; Wang H; Xiong M; Zhou W
    Stem Cell Res; 2024 Apr; 76():103345. PubMed ID: 38382213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular findings of albinism in
    Ernst J; Alabek ML; Eldib A; Madan-Khetarpal S; Sebastian J; Bhatia A; Liasis A; Nischal KK
    Ophthalmic Genet; 2020 Dec; 41(6):650-655. PubMed ID: 32838606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tregs and Th17 lymphocytes in human DYRK1A haploinsufficiency.
    Valencic E; Piscianz E; Sirchia F; Tommasini A; Faletra F; Todaro F; Spinelli AM; Badolato R
    Immunol Lett; 2019 Oct; 214():52-54. PubMed ID: 31442541
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural analysis of pathogenic mutations in the DYRK1A gene in patients with developmental disorders.
    Evers JM; Laskowski RA; Bertolli M; Clayton-Smith J; Deshpande C; Eason J; Elmslie F; Flinter F; Gardiner C; Hurst JA; Kingston H; Kini U; Lampe AK; Lim D; Male A; Naik S; Parker MJ; Price S; Robert L; Sarkar A; Straub V; Woods G; Thornton JM; ; Wright CF
    Hum Mol Genet; 2017 Feb; 26(3):519-526. PubMed ID: 28053047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of a de novo interstitial 21q22.12q22.13 deletion in a patient with intellectual disability].
    Peng Y; Jia Z; Pang J; Hu J; Xi H; Wang H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Jul; 36(7):704-707. PubMed ID: 31302916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DYRK1A-related intellectual disability: a syndrome associated with congenital anomalies of the kidney and urinary tract.
    Blackburn ATM; Bekheirnia N; Uma VC; Corkins ME; Xu Y; Rosenfeld JA; Bainbridge MN; Yang Y; Liu P; Madan-Khetarpal S; Delgado MR; Hudgins L; Krantz I; Rodriguez-Buritica D; Wheeler PG; Al-Gazali L; Mohamed Saeed Mohamed Al Shamsi A; Gomez-Ospina N; Chao HT; Mirzaa GM; Scheuerle AE; Kukolich MK; Scaglia F; Eng C; Willsey HR; Braun MC; Lamb DJ; Miller RK; Bekheirnia MR
    Genet Med; 2019 Dec; 21(12):2755-2764. PubMed ID: 31263215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.
    Altafaj X; Dierssen M; Baamonde C; Martí E; Visa J; Guimerà J; Oset M; González JR; Flórez J; Fillat C; Estivill X
    Hum Mol Genet; 2001 Sep; 10(18):1915-23. PubMed ID: 11555628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Mutation of SYNGAP1 Associated with Autosomal Dominant Mental Retardation 5 in a Chinese Patient.
    Pei Y; Li W; Du L; Wei F
    Fetal Pediatr Pathol; 2018 Dec; 37(6):400-403. PubMed ID: 30572772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative approach to interpret DYRK1A variants, leading to a frequent neurodevelopmental disorder.
    Courraud J; Chater-Diehl E; Durand B; Vincent M; Del Mar Muniz Moreno M; Boujelbene I; Drouot N; Genschik L; Schaefer E; Nizon M; Gerard B; Abramowicz M; Cogné B; Bronicki L; Burglen L; Barth M; Charles P; Colin E; Coubes C; David A; Delobel B; Demurger F; Passemard S; Denommé AS; Faivre L; Feger C; Fradin M; Francannet C; Genevieve D; Goldenberg A; Guerrot AM; Isidor B; Johannesen KM; Keren B; Kibæk M; Kuentz P; Mathieu-Dramard M; Demeer B; Metreau J; Steensbjerre Møller R; Moutton S; Pasquier L; Pilekær Sørensen K; Perrin L; Renaud M; Saugier P; Rio M; Svane J; Thevenon J; Tran Mau Them F; Tronhjem CE; Vitobello A; Layet V; Auvin S; Khachnaoui K; Birling MC; Drunat S; Bayat A; Dubourg C; El Chehadeh S; Fagerberg C; Mignot C; Guipponi M; Bienvenu T; Herault Y; Thompson J; Willems M; Mandel JL; Weksberg R; Piton A
    Genet Med; 2021 Nov; 23(11):2150-2159. PubMed ID: 34345024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of phenotypic range in DYRK1A haploinsufficiency syndrome using standardized behavioral measures.
    Fenster R; Ziegler A; Kentros C; Geltzeiler A; Green Snyder L; Brooks E; Chung WK
    Am J Med Genet A; 2022 Jul; 188(7):1954-1963. PubMed ID: 35285131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intragenic deletion in DYRK1A leads to mental retardation and primary microcephaly.
    van Bon BW; Hoischen A; Hehir-Kwa J; de Brouwer AP; Ruivenkamp C; Gijsbers AC; Marcelis CL; de Leeuw N; Veltman JA; Brunner HG; de Vries BB
    Clin Genet; 2011 Mar; 79(3):296-9. PubMed ID: 21294719
    [No Abstract]   [Full Text] [Related]  

  • 20. Dyrk1a Mutations Cause Undergrowth of Cortical Pyramidal Neurons via Dysregulated Growth Factor Signaling.
    Levy JA; LaFlamme CW; Tsaprailis G; Crynen G; Page DT
    Biol Psychiatry; 2021 Sep; 90(5):295-306. PubMed ID: 33840455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.